Annual report pursuant to section 13 and 15(d)

Stockholders' Equity - Schedule of Asset and Liabilities (Details)

v2.4.0.8
Stockholders' Equity - Schedule of Asset and Liabilities (Details) (USD $)
Dec. 31, 2013
Dec. 31, 2012
May 31, 2006
Hawaii Biotech, Inc [Member]
Cash     $ 7,007,371
Due from Hawaii Biotech, Inc.     1,000,000
Prepaid expenses     14,279
Employee note receivable     288,576
Fixed assets, net of depreciation of $181,905     388,165
Other assets     606
Total assets 1,768,482 1,481,774 8,698,997
Accounts and accrued expenses payable     138,921
Due to Hawaii Biotech, Inc.     70,279
Equipment leases payable     181,203
Total liabilities 14,704,594 10,066,598 390,403
Net assets transferred     8,308,594
Depreciation on fixed asset $ 1,007,176 $ 1,001,554 $ 181,905